copyrightpsasir.upm.edu.my/21581/1/fpsk(m)_2011_31r.pdf · rusni binti mohd jas . september 2011 ....
TRANSCRIPT
© COPYRIG
HT UPM
UNIVERSITI PUTRA MALAYSIA
REAL-TIME HIGH RESOLUTION MELTING ANALYSIS-PCR FOR ASSESSMENT OF GENE MUTATIONS IN HUMAN AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE
RUSNI BINTI MOHD JAS
FPSK(m) 2011 31
© COPYRIG
HT UPM
REAL-TIME HIGH RESOLUTION MELTING ANALYSIS-PCR FOR
ASSESSMENT OF GENE MUTATIONS IN HUMAN AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE
By
RUSNI BINTI MOHD JAS
Thesis Submitted to the School of Graduate Studies, Universiti Putra Malaysia, in
Fulfilment of the Requirement for the Degree of Master of Science
September 2011
© COPYRIG
HT UPM
ii
Abstract of thesis presented to the Senate of Universiti Putra Malaysia in fulfilment of
the requirement for the degree of Master of Science
REAL-TIME HIGH RESOLUTION MELTING ANALYSIS-PCR FOR
ASSESSMENT OF GENE MUTATIONS IN HUMAN AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE
By
RUSNI BINTI MOHD JAS
September 2011
Chair: Patimah Ismail, PhD
Faculty: Medicine and Health Sciences
Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common
hereditary renal diseases that affect 1 in 400 to 1 in 1000 life birth and cause by
mutations in two known genes; PKD1 and PKD2. Although the manifestation of Type1
ADPKD is similar to Type2, it is more severe and patients suffer total renal failure by
the fifth decade of life. In finding the mutations occurring in both genes, PCR-based
methodology have been used and all require technical expertise, otherwise are time
consuming and costly. Therefore, this study aims to develop a much rapid screening
© COPYRIG
HT UPM
iii
procedure that is cost effective but have the same sensitivity to widely used
methodology to differentiate ADPKD samples from control. Fourteen primers were
selected and used to amplify the target genes by using Real-time High Resolution
Melting Analysis PCR (Real-time HRMA PCR) and was compared to PCR-SSCP in
terms of rapidity, sensitivity and reliability. PCR-SSCP revealed same number of bands
in control and case sample, with different only in the bands’ size. All primers
successfully amplified respective genes in Real-time HRMA PCR. Ten primers had two
apparent melting curves which enabled control and case samples to be differentiated.
The mean melting temperature for control samples of the ten primers was 81.38±1.70oC
whereas in case samples the mean was 81.00±1.68oC. The p value was 0.001. The
melting curves of control were all shifted to the right having higher melting temperature
while case melting curves were shifted to the left due to lower melting temperature.
Possible mutations were found to be present in five of these primers due to lone case
samples where the melting curve were shifted differently from control and case melting
curves and cannot be classified either in control or case group (p<0.001). Three primers
were found to be less useful to be used in Real-time HRMA PCR as control and case
samples melted in the same manner with same exact temperature, resulting in
inconclusive results. While other primers conferred single melting domain, a primer
amplifying the PKD1 gene was melted twice and evidence in both samples. The PCR-
SSCP needs more time to be completed (mean; 13.93±0.94 hours) before analysis can
be done while the Real-time HRMA PCR can be completed in a very short time (mean;
2.40±0.54 hours) including the analysis. Both methodologies are able to discriminate
case from control but Real-time HRMA PCR is more rapid (p<0.001). Since Real-time
© COPYRIG
HT UPM
iv
HRMA PCR is more rapid and less procedure is needed, it is proven to be better for
gene mutation screening. In conclusion, the Real-time HRMA PCR is not only sensitive,
but it can screen for control and ADPKD samples more rapidly and more reliable with
the application of commonly used primers in conventional PCR.
© COPYRIG
HT UPM
v
Abstrak tesis yang dikemukakan kepada Senat Universiti Putra Malaysia sebagai
memenuhi keperluan untuk ijazah Master Sains
REAL-TIME HIGH RESOLUTION PCR UNTUK PENYARINGAN MUTASI
GEN PESAKIT AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE
Oleh
RUSNI BINTI MOHD JAS
September 2011
Pengerusi: Patimah Ismail, PhD
Fakulti: Perubatan dan Sains Kesihatan
Autosomal dominant polycystic kidney disease (ADPKD) merupakan salah satu
penyakit genetik buah pinggang yang paling biasa dialami dengan nisbah 1 dalam 400
atau 1 dalam 1000 kelahiran hidup dan penyakit ini disebabkan mutasi yang berlaku
kepada dua gen yang telah dikenalpasti; gen PKD1 dan gen PKD2. Walaupun ciri-ciri
Jenis1 dan Jenis2 adalah serupa, Jenis1 lebih serius dan pesakit akan mengalami
kegagalan buah pinggang yang memerlukan rawatan dialisis sepanjang hayat semasa
© COPYRIG
HT UPM
vi
mereka berumur lewat 50-an. Untuk mengenalpasti mutasi yang berlaku di dalam
kedua-dua gen tersebut, teknologi yang berasaskan PCR telah digunakan dan kesemua
teknologi ini memerlukan kemahiran teknikal, paling tidak pun memerlukan banyak
masa dengan kos yang mahal. Oleh itu, tujuan utama kajian ini adalah untuk membina-
uji satu kaedah yang lebih pantas dan efektif bukan sahaja daripada segi kos, tetapi juga
mempunyai sensitiviti yang setaraf dengan kaedah yang biasa digunakan untuk
membezakan sampel pesakit ADPKD daripada sampel kawalan. Sebanyak 14 primer
dipilih dan digunakan untuk kaedah Real-time HRMA PCR dan dibandingkan dengan
kaedah PCR-SSCP daripada segi kepantasan, sensitiviti dan ‘realibility’. Hasil PCR-
SSCP menunjukkan kehadiran jalur-jalur DNA dalam jumlah yang sama diantara
pesakit dan kawalan, cuma berbeza daripada segi saiz jalur. Kesemua primer berjaya
digunakan di dalam kaedah Real-time HRMA PCR. Sepuluh primer mempunyai dua
lengkung pencairan yang berbeza, setiap satu mewakili sampel pesakit dan kawalan
yang membolehkan perbezaan sampel dilakukan. Purata suhu pencairan bagi kawalan
adalah 81.37±1.70oC manakala bagi sampel pesakit adalah 81.01±1.68
oC. Lengkung
pencairan untuk kawalan beranjak lebih ke kanan kerana suhu pencairan yang lebih
tinggi manakala lengkung pencairan pesakit beranjak ke kiri disebabkan suhu pencairan
yang lebih rendah (p<0.001). Tiga primer didapati tidak boleh digunakan dalam kaedah
Real-time HRMA PCR kerana sampel pesakit dan kawalan mempunyai suhu dan
lengkung pencairan yang sama menyebabkan tiada kesimpulan dapat dibuat. Hanya satu
primer didapati mempunyai dua domain pencairan; kedua-dua sampel pesakit dan
kawalan dicairkan dua kali, sementara yang lain hanya mempunyai satu domain
pencairan. PCR-SSCP memerlukan lebih masa untuk disiapkan (purata masa;
© COPYRIG
HT UPM
vii
13.93±0.94 jam) sementara Real-time HRMA PCR memerlukan masa yang sangat
singkat (purata masa; 2.40±0.54 jam). Kedua-dua cara berupaya untuk membezakan
sampel pesakit daripada sampel kawalan tetapi Real-time HRMA PCR adalah lebih
pantas (p<0.001). Disebabkan kepantasan dan kurangnya prosedur eksperimen, Real-
time HRMA PCR dibuktikan lebih baik untuk penyaringan mutasi gen. Sebagai
kesimpulan, Real-time HRMA PCR bukan sahaja sensitif, tetapi ia boleh menyaring
sampel kawalan dan pesakit ADPKD dengan lebih cepat dan ‘reliable’ menggunakan
primer sedia ada yang digunakan di dalam PCR biasa.
© COPYRIG
HT UPM
viii
ACKNOWLEDGEMENTS
In the name of Allah swt, the most Gracious and most Merciful, and selawat to the
prophet, Muhammad saw, Alhamdulillah.
I have completed my research.
Thank you to my supervisor, Prof. Dr. Patimah Ismail for her priceless guidance, help
and patience throughout the research and to my co-supervisor, Assoc. Prof. Dr. Saidi
Moin and Assoc. Prof. Dr. Abdul Halim Abdul Gafor.
Thank you to Dr. R.Vasudevan for the advice in my laboratory work and all the staffs in
Molecular Biology Lab, FMHS, UPM.
To Mimi Soraya M and Aisyah A, all my labmates and friends, thank you for all the
sweat, blood and tears we all went through. It is indeed, a journey of adding values.
With love to my family members, for their understandings and support.
May Allah bless us all.
© COPYRIG
HT UPM
ix
I certify that a Thesis Examination Committee has met on 30 September 2011 to
conduct a final examination of Rusni binti Mohd Jas on her thesis entitled “Real-time
High Resolution Melting Analysis-PCR for Assessment of Gene Mutations in
Human Autosomal Dominant Polycystic Kidney Disease” in accordance with the
Universities and University Colleges Act 1971 and the Constitution of the Universiti
Putra Malaysia [P.U.A(A) 106] 15 March 1998. The Committee recommends that the
student be awarded the Master of Science.
Members of the Thesis Examination Committee were as follows:
Fauziah Othman, PhD
Professor
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
(Chairman)
Chong Pei Pei, PhD
Associate Professor
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
(Internal Examiner)
Abdul Aziz Dollah, PhD
Associate Professor
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
(Internal Examiner)
Srikumar Chakravarthy, PhD
Lecturer
Department of Pathology
International Medical University (IMU)
(External Examiner)
________________________
SEOW HENG FONG, PhD
Professor and Deputy Dean
School of Graduate Studies
Universiti Putra Malaysia
Date: 20 December 2011
© COPYRIG
HT UPM
x
This thesis was submitted to the Senate of Universiti Putra Malaysia and has been
accepted as fulfilment of the requirement for the degree of Master of Science. The
members of the Supervisory Committee were as follows:
Patimah Ismail, PhD
Professor
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
(Chairman)
Saidi Moin, PhD
Associate Professor
Faculty of Medicine and Health Sciences
Universiti Putra Malaysia
(Member)
Abdul Halim Abdul Gafor
Associate Professor
Faculty of Medicine
Universiti Kebangsaan Malaysia
(Member)
______________________________
BUJANG BIN KIM HUAT, PhD
Professor and Dean
School of Graduate Studies
Universiti Putra Malaysia
Date:
© COPYRIG
HT UPM
xi
DECLARATION
I declare that the thesis is my original work except for quotations and citation which
have been dully acknowledged. I also declare that it has not been previously, and is not
concurrently, submitted for any other degree at Universiti Putra Malaysia or at any other
institution.
_______________________
RUSNI BINTI MOHD JAS
Date: 30 September 2011
© COPYRIG
HT UPM
xii
TABLE OF CONTENTS
Page
ABSTRACT ii
ABSTRAK v
ACKNOWLEDGEMENTS viii
APPROVAL ix
DECLARATION x1
LIST OF TABLES xv
LIST OF FIGURES xvi
LIST OF ABBREVIATIONS xviii
CHAPTER
1 INTRODUCTION 1
1.1 Introduction 1
1.2 Problem Statement 3
1.3 Objectives 4
1.4 Hypothesis 5
2 LITERATURE REVIEW 6
2.1 Autosomal Dominant Polycystic Kidney Disease 6
2.1.1 Polycystic Kidney Disease 6
2.1.2 Epidemiology 6
2.1.3 Molecular Genetics
2.1.3.1 Polycystic Kidney Disease (PKD) Genes and
Polycystins
2.1.3.2 Polycystins Roles in ADPKD
7
8
11
2.1.4 Pathogenesis of Cyst
2.1.4.1 The Two-hit Model
2.1.4.1.1 Loss of Heterozygosity (LOH)
2.1.4.2 The trans-heterozygous Mutations
2.1.4.3 Pathological Features of ADPKD
13
14
16
16
17
2.1.5 Complications, Renal and Extra Renal Manifestation 18
2.1.6 Disease Outcome 20
2.1.7 Clinical Diagnosis 21
2.1.8 Factors Affecting Disease Progression 24
2.1.9 Treatment 26
2.2 Mutation Screening 26
2.2.1 Introduction 26
2.2.2 Polymerase Chain Reaction (PCR)
2.2.2.1 Background
2.2.2.2 Principle
28
28
28
2.2.3 Agarose Gel Electrophoresis 29
© COPYRIG
HT UPM
xiii
2.2.3.1 Background
2.2.3.2 Viewing the Gel
29
30
2.2.4 Single Stranded Conformation Polymorphism (SSCP)
2.2.4.1 Background
2.2.4.2 The Principle of SSCP
2.2.4.3 Applications in Genetics
31
31
31
33
2.2.5 Real-Time PCR 33
2.2.6 High Resolution Melting Analysis (HRMA)
2.2.6.1 Background
2.2.6.2 The Principle of HRMA
2.2.6.3 Primer Design
2.2.6.4 Saturating Dyes
2.2.6.5 Applications of HRMA
2.2.6.6 Advantages and Drawbacks of HRMA
34
34
35
36
37
39
42
3 METHODOLOGY 44
3.1 Approval of Study 44
3.2 Location 44
3.3 Study Design 45
3.4 Sampling
3.4.1 Study Population
3.4.2 Sample Unit
45
45
45
3.5 Instrument of Study
3.5.1 Sample Collection and Preparation
3.5.1.1 DNA Extraction
3.5.1.2 DNA Quantification
3.5.2 Polymerase Chain Reaction (PCR)
3.5.2.1 Optimization of PCR
3.5.2.2 Agarose Gel Electrophoresis
3.5.3 PCR-SSCP
3.5.4 Real-time HRMA with Pre-amplification
46
46
47
48
48
50
51
52
52
3.6 Data Analysis 53
4 RESULTS AND DISCUSSION 54
4.1 Subjects 54
4.2 DNA Extraction from Buccal Samples 58
4.3 PCR Optimizations 59
4.4 PCR-SSCP Analysis 59
4.5 DNA Amplification in Real-time PCR 62
4.6 HRMA
4.6.1 Primers with Distinguishable Melting Point for
Control and Case
4.6.2 Primers with a Single Melting Point for Control and
Case
68
69
79
© COPYRIG
HT UPM
xiv
4.6.3 Primers with Two Melting Domains 83
4.7 Comparison of PCR-SSCP and Real-time HRMA PCR 86
5 SUMARRY, CONCLUSION AND
RECOMMENDATIONS FOR FUTURE RESEARCH
89
5.1 Summary 89
5.1 Conclusion 90
5.2 Recommendations for Future Research 90
REFERENCES 92
APPENDICES 100
BIODATA OF STUDENT 114